Your browser doesn't support javascript.
loading
ARID4B is a good biomarker to predict tumour behaviour and decide WHO grades in gliomas and meningiomas.
Tsai, Wen-Chiuan; Hueng, Dueng-Yuan; Nieh, Shin; Gao, Hong-Wei.
Affiliation
  • Tsai WC; Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
  • Hueng DY; Graduate Institute of Engineering Technology, College of Engineering, National Taipei University of Technology, Taipei, Taiwan.
  • Nieh S; Department of Neurological Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
  • Gao HW; Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
J Clin Pathol ; 70(2): 162-167, 2017 Feb.
Article in En | MEDLINE | ID: mdl-27451434
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Biomarkers, Tumor / Glioma / Meningeal Neoplasms / Meningioma / Antigens, Neoplasm / Neoplasm Proteins Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Clin Pathol Year: 2017 Document type: Article Affiliation country: Taiwan Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Biomarkers, Tumor / Glioma / Meningeal Neoplasms / Meningioma / Antigens, Neoplasm / Neoplasm Proteins Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Clin Pathol Year: 2017 Document type: Article Affiliation country: Taiwan Country of publication: United kingdom